Response to the case report by Mattar: Generic Imatinib (Imatib, Cipla) in a patient with chronic myeloid leukemia in chronic phase

Int J Hematol. 2010 Dec;92(5):772-3. doi: 10.1007/s12185-010-0718-2. Epub 2010 Nov 18.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Drugs, Generic / administration & dosage
  • Drugs, Generic / adverse effects
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelomonocytic, Chronic / drug therapy*
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Treatment Failure

Substances

  • Antineoplastic Agents
  • Benzamides
  • Drugs, Generic
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate